McGuire is a chief medical resident at University of Utah Health, where he works with patients rehabilitating from cancer and injuries, but he had never heard of the substance, called BPC-157
Last reviewed: May 17, 2026 Last updated: May 17, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
# reports significance with respect to w/o C4 (50 L)
The Path to Complete Recovery Non-healing injuries can improve when you address biology and movement at the same time
A maternal injection of IL-6 on E12.5 was sufficient to cause behavioral alterations of preference for social novelty in offspring